{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:08:49Z","timestamp":1792822129435,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ygyno.2024.06.012","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T17:50:08Z","timestamp":1719424208000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Scalp hypothermia to reduce chemotherapy-induced alopecia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"188","author":[{"given":"Katherine A.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin B.","family":"Albright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Katherine","family":"Anastasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2024.06.012_bb0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jocd.12308","article-title":"Chemotherapy-induced alopecia management: clinical experience and practical advice","volume":"16","author":"Rossi","year":"2017","journal-title":"J. Cosmet. Dermatol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.012_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1634\/theoncologist.2017-0263","article-title":"A clinical and biological guide for understanding chemotherapy-induced alopecia and its prevention","volume":"23","author":"Dunnill","year":"2018","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.ygyno.2024.06.012_bb0015","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","article-title":"Hair disorders in patients with cancer","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.06.012_bb0020","first-page":"5","article-title":"Chemotherapy-induced hair loss","volume":"15","author":"Tr\u00fceb","year":"2010","journal-title":"Skin Ther. Lett."},{"issue":"6","key":"10.1016\/j.ygyno.2024.06.012_bb0025","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bjc.1993.488","article-title":"Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines","volume":"68","author":"Liebmann","year":"1993","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.012_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1471-6712.1992.tb00128.x","article-title":"Knowledge, expectations and experiences of patients receiving chemotherapy for breast cancer","volume":"6","author":"Tierney","year":"1992","journal-title":"Scand. J. Caring Sci."},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.012_bb0050","first-page":"139","article-title":"Changes in self-concept and body image during alopecia induced cancer chemotherapy","volume":"5","author":"M\u00fcnstedt","year":"1997","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2024.06.012_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/ecc.12056","article-title":"The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer","volume":"22","author":"Jayde","year":"2013","journal-title":"Eur. J. Cancer Care (Engl.)"},{"issue":"4","key":"10.1016\/j.ygyno.2024.06.012_bb0060","first-page":"741","article-title":"Symptom management in patients with cancer of the female reproductive system receiving chemotherapy","volume":"9","author":"Phianmongkhol","year":"2008","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.012_bb0065","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.7314\/APJCP.2015.16.3.1225","article-title":"Psychosocial reaction patterns to alopecia in female patients with gynecological cancer undergoing chemotherapy","volume":"16","author":"Ishida","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.012_bb0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/annonc\/mdi088","article-title":"Prevention of chemotherapy-induced hair loss by scalp cooling","volume":"16","author":"Grevelman","year":"2005","journal-title":"Ann. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.ygyno.2024.06.012_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11626-007-9074-9","article-title":"Effects of temperature and doxorubicin exposure on keratinocyte damage in vitro","volume":"44","author":"Janssen","year":"2008","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"6","key":"10.1016\/j.ygyno.2024.06.012_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/00365518509155250","article-title":"Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man","volume":"45","author":"B\u00fclow","year":"1985","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"7","key":"10.1016\/j.ygyno.2024.06.012_bb0085","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1634\/theoncologist.2012-0332","article-title":"Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia","volume":"18","author":"Komen","year":"2013","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.ygyno.2024.06.012_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"9","key":"10.1016\/j.ygyno.2024.06.012_bb0115","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.012_bb0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/030089161009600214","article-title":"The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia","volume":"96","author":"Auvinen","year":"2010","journal-title":"Tumori J."},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.012_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000501393","article-title":"EVA-scalp: evaluation of patient satisfaction with a scalp cooling device to prevent chemotherapy-induced alopecia in breast cancer patients","volume":"15","author":"Bitto","year":"2020","journal-title":"Breast Care"},{"issue":"10","key":"10.1016\/j.ygyno.2024.06.012_bb0130","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.3390\/curroncol29100569","article-title":"Prospective study investigating the efficacy and safety of a scalp cooling device for the prevention of alopecia in women undergoing (neo)adjuvant chemotherapy for breast cancer","volume":"29","author":"Carbognin","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ygyno.2024.06.012_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.breast.2018.07.006","article-title":"Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens","volume":"41","author":"Chan","year":"2018","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.ygyno.2024.06.012_bb0140","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clbc.2015.01.003","article-title":"Efficacy of scalp cooling in preventing chemotherapy-induced alopecia in breast cancer patients receiving adjuvant docetaxel and cyclophosphamide chemotherapy","volume":"15","author":"Cigler","year":"2015","journal-title":"Clin. Breast Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.012_bb0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10549-020-06063-w","article-title":"Scalp cooling in breast cancer patients treated with docetaxel\u2013cyclophosphamide: patient- and nurse-reported results","volume":"186","author":"Coolbrandt","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.ygyno.2024.06.012_bb0150","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3747\/co.23.3200","article-title":"Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients","volume":"23","author":"Fehr","year":"2016","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.012_bb0155","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/2193-1801-3-500","article-title":"Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer \u2013 clinical evaluation of sensor-controlled scalp cooling","volume":"3","author":"Friedrichs","year":"2014","journal-title":"SpringerPlus"},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.012_bb0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/apjon.apjon_4_19","article-title":"Scalp cooling in daily clinical practice for breast cancer patients undergoing curative chemotherapy: amulticenter interventional study","volume":"6","author":"Gianotti","year":"2019","journal-title":"Asia-Pac. J. Oncol. Nurs."},{"issue":"7","key":"10.1016\/j.ygyno.2024.06.012_bb0165","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/tbj.13711","article-title":"Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: a prospective study","volume":"26","author":"Giarratano","year":"2020","journal-title":"Breast J."},{"key":"10.1016\/j.ygyno.2024.06.012_bb0170","article-title":"Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - a single center prospective study","volume":"26","author":"Kate","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"issue":"6","key":"10.1016\/j.ygyno.2024.06.012_bb0175","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0959-8049(00)00012-5","article-title":"Prevention of chemotherapy-induced alopecia using an effective scalp cooling system","volume":"36","author":"Katsimbri","year":"2000","journal-title":"Eur. J. Cancer"},{"issue":"7\u20138","key":"10.1016\/j.ygyno.2024.06.012_bb0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000523759","article-title":"Scalp cooling for prevention of chemotherapy-induced alopecia for women and men with various cancer entities: atwo-year survey of an outpatient cancer center in Germany","volume":"45","author":"Keim","year":"2022","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.ygyno.2024.06.012_bb0185","article-title":"Scalp cooling for reducing alopecia in gynecology oncology patients treated with dose-dense chemotherapy: a pilot project","volume":"37","author":"Mitric","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"issue":"4","key":"10.1016\/j.ygyno.2024.06.012_bb0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41416-019-0520-8","article-title":"Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines","volume":"121","author":"Munzone","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.012_bb0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00520-020-05506-w","article-title":"Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy","volume":"29","author":"Ohsumi","year":"2021","journal-title":"Support Care Cancer"},{"issue":"29","key":"10.1016\/j.ygyno.2024.06.012_bb0200","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2217\/fon-2019-0066","article-title":"Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia","volume":"15","author":"Orlando","year":"2019","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.012_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/ijn.12888","article-title":"Efficacy of the Dignicap system in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device","volume":"27","author":"Pedersini","year":"2021","journal-title":"Int. J. Nurs. Pract."},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.012_bb0210","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1574887113666181120111104","article-title":"Hair loss prevention by a scalp cooling device in early breast cancer patients: the Poliambulanza preliminary experience","volume":"14","author":"Prochilo","year":"2019","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0215","article-title":"Manual scalp cooling in early-stage breast cancer case report: value of caretaker training and patient experience to optimize efficacy and patient selection","volume":"4","author":"Rezayee","year":"2021","journal-title":"Curr. Probl. Cancer Case Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.012_bb0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-017-4506-z","article-title":"Registry study to assess hair loss prevention with the Penguin cold cap in breast cancer patients receiving chemotherapy","volume":"167","author":"Rice","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.ygyno.2024.06.012_bb0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000440636","article-title":"The influence of various parameters on the success of sensor-controlled scalp cooling in preventing chemotherapy-induced alopecia","volume":"38","author":"Schaffrin-Nabe","year":"2015","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.ygyno.2024.06.012_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2018.04.012","article-title":"Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline\/taxane-based chemotherapy","volume":"40","author":"Vasconcelos","year":"2018","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.012_bb0235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10549-020-05968-w","article-title":"Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention","volume":"185","author":"Villarreal-Garza","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2024.06.012_bb0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.breast.2019.12.004","article-title":"Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia","volume":"49","author":"Bajpai","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.breast.2022.04.008","article-title":"Hair safe study: effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - a prospective interventional study","volume":"64","author":"Brunner","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0250","first-page":"9","article-title":"Efficacy of scalp cooling in preventing and recovering from chemotherapy-induced alopecia in breast cancer patients: the HOPE study","author":"Kinoshita","year":"2019","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2024.06.012_bb0255","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.2016.20939","article-title":"Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer","volume":"317","author":"Nangia","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ygyno.2024.06.012_bb0260","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2016.21038","article-title":"Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer","volume":"317","author":"Rugo","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.012_bb0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/ijc.IJC_581_17","article-title":"The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy in an Asian setting","volume":"55","author":"Saad","year":"2018","journal-title":"Indian J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.012_bb0270","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-018-4983-8","article-title":"COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer","volume":"173","author":"Smetanay","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.ygyno.2024.06.012_bb0275","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jamadermatol.2018.3465","article-title":"Evaluation of prevention interventions for taxane-induced dermatologic adverse events: asystematic review","volume":"154","author":"Marks","year":"2018","journal-title":"JAMA Dermatol."},{"issue":"11","key":"10.1016\/j.ygyno.2024.06.012_bb0280","first-page":"6943","article-title":"The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis","volume":"29","author":"Wang","year":"2021","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2024.06.012_bb0285","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.18632\/aging.203919","article-title":"Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis","volume":"14","author":"Lin","year":"2022","journal-title":"Aging"},{"issue":"8031","key":"10.1016\/j.ygyno.2024.06.012_bb0290","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(77)92877-X","article-title":"Doxorubicin-induced hair loss and possible modification by scalp cooling","volume":"2","author":"Edelstyn","year":"1977","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0295","series-title":"FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy","author":"Commissioner O of the","year":"2020"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0300","series-title":"FDA Clearance for Expanded Indication - Paxman USA Scalp Cooling","author":"Leaf","year":"2018"},{"issue":"8","key":"10.1016\/j.ygyno.2024.06.012_bb0305","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/annonc\/mdx265","article-title":"First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study","volume":"28","author":"Zhu","year":"2017","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.06.012_bb0310","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10865-011-9379-8","article-title":"The impact of emotional well-being on long-term recovery and survival in physical illness: a meta-analysis","volume":"35","author":"Lamers","year":"2012","journal-title":"J. Behav. Med."},{"issue":"11","key":"10.1016\/j.ygyno.2024.06.012_bb0315","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: a meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ygyno.2024.06.012_bb0325","author":"Cost"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0330","series-title":"US Scalp Cooling Access and Support | Paxman Scalp Cooling","year":"2024"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0335","series-title":"Cancer of the Breast (Female) - Cancer Stat Facts","year":"2024"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0340","series-title":"Cancer of the Ovary - Cancer Stat Facts","year":"2024"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0345","series-title":"Cancer of the Endometrium - Cancer Stat Facts","year":"2024"},{"key":"10.1016\/j.ygyno.2024.06.012_bb0350","series-title":"Cancer of the Cervix Uteri - Cancer Stat Facts","year":"2024"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824003275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824003275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:23:32Z","timestamp":1738704212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824003275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":62,"alternative-id":["S0090825824003275"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scalp hypothermia to reduce chemotherapy-induced alopecia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}